Can Pfizer (PFE) Run Higher on Rising Earnings Estimates?
https://www.zacks.com/stock/news/2315509/can-pfizer-pfe-run-higher-on-rising-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2315509
Aug 02, 2024 - Pfizer (PFE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
PFE vs. NVO: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2315429/pfe-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2315429
Aug 02, 2024 - PFE vs. NVO: Which Stock Is the Better Value Option?
0
Are Investors Undervaluing Pfizer (PFE) Right Now?
https://www.zacks.com/stock/news/2315200/are-investors-undervaluing-pfizer-pfe-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2315200
Aug 02, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Pfizer (PFE) Q2 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/07/30/pfizer-pfe-q2-2024-earnings-call-transcript/?source=iedfolrf0000001
Jul 30, 2024 - PFE earnings call for the period ending June 30, 2024.
0
Prediction: This Will Be Pfizer's Next Big Move
https://www.fool.com/investing/2024/07/29/prediction-this-will-be-pfizers-next-big-move/?source=iedfolrf0000001
Jul 29, 2024 - One market in particular is too lucrative for it to miss out on any longer.
0
2 Incredibly Cheap Healthcare Stocks to Buy Now
https://www.fool.com/investing/2024/07/28/2-incredibly-cheap-healthcare-stocks-to-buy-now/?source=iedfolrf0000001
Jul 28, 2024 - Sometimes a beaten-down stock can present a valuable opportunity.
0
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $200
https://www.fool.com/investing/2024/07/27/2-unstoppable-growth-stocks-to-buy-right-now-200/?source=iedfolrf0000001
Jul 27, 2024 - These stocks are trading on sale, but a closer look from investors is warranted.
0
3 Surprisingly Underrated Stocks to Buy Right Now
https://www.fool.com/investing/2024/07/26/3-surprisingly-underrated-stocks-to-buy-right-now/?source=iedfolrf0000001
Jul 26, 2024 - These stocks arguably deserve more respect from investors.
0
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
https://www.zacks.com/stock/news/2310103/pharma-stock-roundup-azn-sny-abbv-q2-earnings-pfe-mrk-s-positive-pipeline-news?cid=CS-ZC-FT-analyst_blog|stock_roundup-2310103
Jul 26, 2024 - AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
0
Bristol-Myers (BMY) Tops on Q2 Earnings, Ups '24 EPS View
https://www.zacks.com/stock/news/2310144/bristol-myers-bmy-tops-on-q2-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2310144
Jul 26, 2024 - Bristol-Myers (BMY) posts impressive second-quarter results, with both earnings and sales beating their respective estimates. The company also raises its annual earnings guidance.
0